Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.

Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and leading to ...

Explore innovative treatments for spinal cord injury in clinical trials, including Lineage's OPC1 and NervGen's NVG-291, ...

The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.

Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.

Find out about Resolution Therapeutics' macrophage therapy, as it just raised $85 million in a series B round.

The U.S. Food and Drug Administration (FDA) recently approved the first two drugs to treat the rare lysosomal storage disorder Niemann-Pick disease type C. Both of these drugs were given the green ...